Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Addgene is open for ordering and depositing; find up-to-date details here. To learn more about how we are supporting COVID-19 research and to find related plasmids, check out our COVID-19 and Coronavirus Plasmids & Resources page.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

MTA Ancillary Agreement: Vanderbilt-Cerulean

Please consult the UBMTA for definitions of ORIGINAL MATERIAL and
RECIPIENT regarding this transfer of the ORIGINAL MATERIAL.

By agreeing to this ancillary agreement, the RECIPIENT acknowledges
the following:

The ORIGINAL MATERIAL may contain Cerulean fluorescent protein, which
is covered by certain issued (7,351,537) and pending patents owned by
the Vanderbilt University.

RECIPIENT understands that the ORIGINAL MATERIAL is experimental in
nature and may have hazardous properties. Vanderbilt University MAKES
NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER
EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE
OF THE ORIGINAL MATERIAL WILL NOT INFRINGE ANY PATENT, COPYRIGHT,
TRADEMARK, OR OTHER PROPRIETARY RIGHTS.

In the event of any conflict between this Ancillary Agreement and the
UBMTA, this Ancillary Agreement shall take precedence.